BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7594771)

  • 1. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
    Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
    Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
    Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devazepide-induced hyperplasia in the rat liver and bile ducts.
    Ohlsson B; Axelson J; Rehfeld JF; Ihse I
    Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
    Borgström A; Axelson J; Ihse I; Rehfeld JF
    Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
    Sundaram S; Dayan AD
    Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
    Feurle GE; Hamscher G; Firat AE
    Pancreas; 1995 Apr; 10(3):281-6. PubMed ID: 7624305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of adrenalectomized rats.
    Manso MA; De Dios I
    Pancreas; 1993 May; 8(3):362-7. PubMed ID: 8483879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
    Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
    Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK stimulates growth of both the pancreas and the liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism.
    Obourn JD; Frame SR; Chiu T; Solomon TE; Cook JC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):116-26. PubMed ID: 9299603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.